Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Virtual Reality Hypnosis for Chronic Pain Reduction (VRHChP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2010 by National Institute of General Medical Sciences (NIGMS)
Sponsor:
Information provided by:
National Institute of General Medical Sciences (NIGMS)
ClinicalTrials.gov Identifier:
NCT01099657
First received: April 1, 2010
Last updated: April 6, 2010
Last verified: March 2010
  Purpose

We would like to determine how well hypnosis works when induced through virtual reality medium for patients who have suffered a major burn injury in the past two years and suffer from chronic pain. These patients are coming back to the outpatient burn and plastic clinic at Harborview Medical Center for routine follow-up. We think that patients will find VR-Hypnosis interesting, and it will help them relax and feel less pain.


Condition Intervention
This Study Focuses on Burn Patients Who Suffer From Chronic Pain.
Behavioral: Virtual Reality Hypnosis for chronic pain
Behavioral: Virtual Reality Distraction for Chronic Pain

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
Official Title: Virtual Reality Hypnosis for Chronic Pain Reduction

Resource links provided by NLM:


Further study details as provided by National Institute of General Medical Sciences (NIGMS):

Primary Outcome Measures:
  • Pain and anxiety [ Time Frame: pre and post VR and then up to one month ] [ Designated as safety issue: No ]
    The subjects will answer questions regarding pain and anxiety at the time of their clinic visit, before and after experiencing virtual reality. Then the subject will be followed for up to one month.


Estimated Enrollment: 30
Study Start Date: June 2007
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Virtual Reality Hypnosis Behavioral: Virtual Reality Hypnosis for chronic pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Hypnosis. After VRH, the will again answer Pain and anxiety questionnaires.
Experimental: Virtual Reality Distraction Behavioral: Virtual Reality Distraction for Chronic Pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Distraction. After VRD, the will again answer Pain and anxiety questionnaires.

  Eligibility

Ages Eligible for Study:   13 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 13 - 75 years
  • Able to complete subjective evaluations of pain
  • English-speaking
  • Able to communicate orally

Exclusion Criteria:

  • Age less than 13 years or greater than 75 years
  • Incapable of indicating subjective evaluation of pain
  • Non-English-speaking (Virtual Reality Hypnosis only available in English)
  • Demonstrating delirium, psychosis, or Organic Brain Disorder
  • Unable to communicate verbally
  • Significant developmental disability
  • Extreme susceptibility to motion sickness
  • Significant head/or neck injury
  • Pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01099657

Contacts
Contact: Shelley Wiechman, Ph.D. 206-744-4439 Wiechman@u.washington.edu
Contact: Maryam Soltani, M.Ed. 206-744-2172 soltani@u.washington.edu

Locations
United States, Washington
Harborview Medical Center Recruiting
Seattle, Washington, United States, 98104
Contact: Shelley Wiechman, Ph.D.    206-744-4439      
Contact: Maryam Soltani, M.Ed.    206-744-2172    soltani@u.washington.edu   
Principal Investigator: Shelley Wiechman, Ph.d.         
Harborview Medical Center Recruiting
Seattle, Washington, United States, 98104
Contact: Shelley Wiechman, Ph.D.    206-744-4439    wiechman@u.washington.edu   
Contact: Maryam Soltani, M.Ed.    206-744-2172    soltani@u.washington.edu   
Principal Investigator: Shelley Wiechman, Ph.D.         
Sponsors and Collaborators
  More Information

No publications provided

Responsible Party: Shelley Wiechman, University of Washington, Rehabilitation Medicine
ClinicalTrials.gov Identifier: NCT01099657     History of Changes
Other Study ID Numbers: 31498-A
Study First Received: April 1, 2010
Last Updated: April 6, 2010
Health Authority: United States: Institutional Review Board
United States: Federal Government

Additional relevant MeSH terms:
Chronic Pain
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on November 20, 2014